Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-indomethacin | Version: 1.0.0-ballot | |||
Draft as of 2018-07-02 | Computable Name: Valueset_indomethacin | |||
Copyright/Legal: (copyright expectations unknown) |
ValueSet containing drug identifiers for indomethacin.
References
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
203365 | Indocin |
1491522 | Tivorbex |
5781 | Indomethacin |
1008069 | Indomethacin / Methocarbamol |
1008657 | Indomethacin / polidocanol |
814504 | Dexamethasone / Indomethacin |
817635 | Indomethacin / Thiamine |
258329 | Indomethacin sodium trihydrate |
1294612 | INDOMETHACIN SODIUM |
206969 | Indomethacin 50 MG Rectal Suppository [Indocin] |
206971 | Indomethacin 5 MG/ML Oral Suspension [Indocin] |
891867 | Indomethacin 75 MG Extended Release Oral Capsule [Indocin] |
1491527 | Indomethacin 20 MG Oral Capsule [Tivorbex] |
1491531 | Indomethacin 40 MG Oral Capsule [Tivorbex] |
567764 | Indomethacin 50 MG [Indocin] |
567771 | Indomethacin 5 MG/ML [Indocin] |
891865 | Indomethacin 75 MG [Indocin] |
1491523 | Indomethacin 20 MG [Tivorbex] |
1491530 | Indomethacin 40 MG [Tivorbex] |
367528 | Indomethacin Rectal Suppository [Indocin] |
891866 | Indomethacin Extended Release Oral Capsule [Indocin] |
92965 | Indomethacin Oral Suspension [Indocin] |
1491524 | Indomethacin Oral Capsule [Tivorbex] |
346508 | Indomethacin 1 MG Injection |
105864 | Indomethacin 50 MG Extended Release Oral Tablet |
105866 | Indomethacin 25 MG Extended Release Oral Tablet |
197817 | Indomethacin 25 MG Oral Capsule |
197818 | Indomethacin 50 MG Oral Capsule |
197819 | Indomethacin 50 MG Rectal Suppository |
250526 | Indomethacin 75 MG Extended Release Oral Tablet |
251255 | Indomethacin 25 MG Extended Release Oral Capsule |
310991 | Indomethacin 5 MG/ML Oral Suspension |
310992 | Indomethacin 75 MG Extended Release Oral Capsule |
392073 | Indomethacin 75 MG Oral Capsule |
199549 | Indomethacin 100 MG Rectal Suppository |
1490727 | Indomethacin 20 MG Oral Capsule |
1491529 | Indomethacin 40 MG Oral Capsule |
247069 | Indomethacin 10 MG/ML Ophthalmic Solution |
1863326 | Indomethacin 1 MG |
316082 | Indomethacin 25 MG |
316083 | Indomethacin 5 MG/ML |
316084 | Indomethacin 50 MG |
316085 | Indomethacin 75 MG |
329869 | Indomethacin 100 MG |
335019 | Indomethacin 20 MG |
1491528 | Indomethacin 40 MG |
335017 | Indomethacin 10 MG/ML |
1863327 | Indomethacin Injection |
370686 | Indomethacin Oral Suspension |
370687 | Indomethacin Oral Capsule |
370688 | Indomethacin Rectal Suppository |
370689 | Indomethacin Extended Release Oral Capsule |
372474 | Indomethacin Extended Release Oral Tablet |
372470 | Indomethacin Ophthalmic Solution |
1156902 | Indomethacin Injectable Product |
1156904 | Indomethacin Oral Liquid Product |
1156905 | Indomethacin Oral Product |
1156906 | Indomethacin Pill |
1156907 | Indomethacin Rectal Product |
1156903 | Indomethacin Ophthalmic Product |
1491525 | Tivorbex Oral Product |
1491526 | Tivorbex Pill |
1172729 | Indocin Oral Liquid Product |
1172730 | Indocin Oral Product |
1172731 | Indocin Pill |
1172732 | Indocin Rectal Product |
Expansion based on codesystem RxNorm version ??rx1
This value set contains 66 concepts.
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |